Volume 7, Issue 4, Pages (October 2010)

Slides:



Advertisements
Similar presentations
IPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening Mahendra Rao Cell Stem Cell Volume 13, Issue 4, Pages (October.
Advertisements

Volume 17, Issue 2, Pages (August 2015)
Generation of Induced Pluripotent Stem Cell Lines from Adult Rat Cells
Volume 3, Issue 3, Pages (September 2014)
Volume 4, Issue 6, Pages (June 2009)
Virtual Karyotyping Reveals Greater Chromosomal Stability in Neural Cells Derived by Transdifferentiation than Those from Stem Cells  Uri Weissbein, Uri.
Volume 9, Issue 2, Pages (August 2011)
Establishment of Endoderm Progenitors by SOX Transcription Factor Expression in Human Embryonic Stem Cells  Cheryle A. Séguin, Jonathan S. Draper, Andras.
Volume 138, Issue 4, Pages (August 2009)
Volume 18, Issue 6, Pages (June 2016)
Volume 5, Issue 1, Pages (July 2009)
Volume 10, Issue 6, Pages (December 2006)
Array-CGH Reveals Recurrent Genomic Changes in Merkel Cell Carcinoma Including Amplification of L-Myc  Kelly G. Paulson, Bianca D. Lemos, Bin Feng, Natalia.
Volume 5, Issue 4, Pages (October 2015)
Volume 7, Issue 6, Pages (December 2010)
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Volume 7, Issue 5, Pages (November 2016)
Large-Scale Analysis Reveals Acquisition of Lineage-Specific Chromosomal Aberrations in Human Adult Stem Cells  Uri Ben-David, Yoav Mayshar, Nissim Benvenisty 
Volume 4, Issue 2, Pages (February 2015)
Volume 15, Issue 5, Pages (November 2014)
Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma
Volume 7, Issue 1, Pages (April 2014)
Volume 20, Issue 4, Pages e6 (April 2017)
Volume 33, Issue 4, Pages (February 2009)
Pluripotent Stem Cells and Disease Modeling
Volume 17, Issue 2, Pages (August 2015)
Volume 11, Issue 1, Pages (July 2012)
Volume 24, Issue 4, Pages (July 2018)
Volume 4, Issue 6, Pages (September 2013)
Volume 2, Issue 2, Pages (February 2008)
Volume 20, Issue 1, Pages (January 2017)
Volume 18, Issue 6, Pages (June 2016)
Volume 20, Issue 4, Pages e6 (April 2017)
Single-Unit Responses Selective for Whole Faces in the Human Amygdala
Pei-Yun Jenny Wu, Paul Nurse  Cell 
Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells  Tomer Halevy, Christian Czech, Nissim.
Volume 13, Issue 1, Pages (July 2013)
Volume 18, Issue 2, Pages (February 2016)
Defining Ploidy-Specific Thresholds in Array Comparative Genomic Hybridization to Improve the Sensitivity of Detection of Single Copy Alterations in Cell.
Volume 46, Issue 1, Pages (April 2012)
Volume 7, Issue 4, Pages (October 2016)
Volume 3, Issue 2, Pages (August 2014)
Volume 16, Issue 9, Pages (August 2016)
Volume 8, Issue 1, Pages (January 2011)
A DNA Replication Mechanism for Generating Nonrecurrent Rearrangements Associated with Genomic Disorders  Jennifer A. Lee, Claudia M.B. Carvalho, James.
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Volume 11, Issue 1, Pages (July 2012)
Volume 1, Issue 1, Pages (June 2013)
Volume 16, Issue 4, Pages (April 2015)
Volume 132, Issue 6, Pages (March 2008)
Volume 10, Issue 6, Pages (December 2006)
Volume 10, Issue 1, Pages (January 2018)
Mark H. Chin, Matteo Pellegrini, Kathrin Plath, William E. Lowry 
Volume 23, Issue 4, Pages (April 2018)
Epigenetic Memory and Preferential Lineage-Specific Differentiation in Induced Pluripotent Stem Cells Derived from Human Pancreatic Islet Beta Cells 
Volume 7, Issue 1, Pages (July 2010)
Volume 7, Issue 2, Pages (August 2010)
Volume 3, Issue 3, Pages (September 2008)
SIRT1 Is Necessary for Proficient Telomere Elongation and Genomic Stability of Induced Pluripotent Stem Cells  Maria Luigia De Bonis, Sagrario Ortega,
Volume 1, Issue 5, Pages (November 2013)
Volume 17, Issue 3, Pages (September 2015)
Short Telomeres in ESCs Lead to Unstable Differentiation
Virtual Karyotyping Reveals Greater Chromosomal Stability in Neural Cells Derived by Transdifferentiation than Those from Stem Cells  Uri Weissbein, Uri.
CNOT3-Dependent mRNA Deadenylation Safeguards the Pluripotent State
Lab-Specific Gene Expression Signatures in Pluripotent Stem Cells
Volume 41, Issue 2, Pages (January 2011)
Volume 18, Issue 3, Pages (March 2016)
C. E. Browne, N. R. Dennis, E. Maher, F. L. Long, J. C. Nicholson, J
TeratoScore: Assessing the Differentiation Potential of Human Pluripotent Stem Cells by Quantitative Expression Analysis of Teratomas  Yishai Avior, Juan Carlos.
Trisomy Correction in Down Syndrome Induced Pluripotent Stem Cells
Presentation transcript:

Volume 7, Issue 4, Pages 521-531 (October 2010) Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells  Yoav Mayshar, Uri Ben-David, Neta Lavon, Juan-Carlos Biancotti, Benjamin Yakir, Amander T. Clark, Kathrin Plath, William E. Lowry, Nissim Benvenisty  Cell Stem Cell  Volume 7, Issue 4, Pages 521-531 (October 2010) DOI: 10.1016/j.stem.2010.07.017 Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 1 Identification of Chromosomal Aberrations in HESCs with Gene Expression Analysis (A–C) Identification of aneuploidy in preimplantation genetic screening (PGS) derived HESC lines: (A) High density SNP-array copy number analysis of: CSES7 (46XX); CSES8 (47XX+17); and CSES21 (47XY+21). (B) Whole chromosome gain analysis of overexpressed genes. Bars represent fold enrichment of overexpressed genes in each particular chromosome relative to the expected random frequency. CSES8 shows significant enrichment of overexpressed genes in chromosome 17 (Bonferroni corrected p value = 1∗10−7 by Expander and 2.1 × 10−9 by EASE), CSES21 shows significant enrichment in chromosome 21 (Bonferroni corrected p value = 4.9 × 10−4 by Expander and 1.1∗10−10 by EASE). (C) Gene expression profile moving average plot demonstrates homogenous overexpression of genes along the abnormal chromosomes. (D–G) Identification of aneuploidy in culture adapted HESCs. (D) Identification of trisomies 12 and 17 in the H14-HSR+ cell line (Baker et al., 2007) by whole-chromosome analysis (Bonferroni corrected p value = 5.5 × 10−18 by Expander and 3.6 × 10−18 by EASE, for chromosome 12; 2.6 × 10−18 by Expander and 1.5 × 10−12 by EASE, for chromosome 17), but not in the normal parental H14 cell line (Table S2). (E) The same trisomies shown by moving average plot. (F) Tandem multiple copy number gain in proximal 17p in the adapted cell line H14-HSR+. (G) Single copy number gain in distal 1p in the chHES-3 cell line (Yang et al., 2008). Two samples of different passages carrying the same aberration 46XX,dup(1)(p32p36) relative to a normal cell line from the same study are shown. Asterisks indicate p value < 1 × 10−4, judged by Expander and EASE location analyses. All significance tests are presented after Bonferroni multiple test correction. Vertical dashed lines represent cytogenetic boundaries of chromosomal aberrations as described in the respective studies. Horizontal colored bars represent piecewise constant fit (PCF) abnormality detection as described in the methods section. For further examples of detection of aneuploidy in HESCs, see also Figure S1. For a detailed list of HESC lines, see Table S1. Cell Stem Cell 2010 7, 521-531DOI: (10.1016/j.stem.2010.07.017) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 2 Identification of Chromosomal Aberrations in HiPSCs (A) Detection of chromosome 1 and chromosome 9 trisomies in p-hiPS01 (Bonferroni corrected p values = 5.0 × 10−32 by Expander and 1.1 × 10−30 by EASE, for chromosome 1; 6.0 × 10−13 by Expander and 3.2 × 10−18 by EASE, for chromosome 9) and p-hiPS02 (Bonferroni corrected p values = 4.0 × 10−33 by Expander and 4.5 × 10−44 by EASE, for chromosome 1; 2.7 × 10−12 by Expander and 2.2 × 10−16 by EASE, for chromosome 9), as well as detection of chromosome 1 and chromosome 9p trisomies in rv-hiPS01 (Bonferroni corrected p values = 1.3 × 10−30 by Expander and 5.0 × 10−46 by EASE, for chromosome 1; 1.4 × 10−7 by Expander and 8.7 × 10−13 by EASE, for chromosomal arm 9p). The original study described trisomy in chromosomes 1 and 9 in p-hiPS01 and p-hiPS02 as well as in the parental somatic cell line (Kim et al., 2009). (B) Moving average plot of the gene expression profile of these cell lines; iPS-DF6_9 is displayed as reference. (C–E) Identification of aneuploidy acquired in culture. (C) Identification of a small deletion described by Yu et al. (2009) in the subclone iPS-DF6_9_12T. All the other clones described in this study were found in our analysis to be normal, congruent with the original report. The parental HiPSC line iPSC-DF6_9 and another subclone isolated from this line (iPS-DF6_9_9T) are presented as normal reference. (D and E) Acquired chromosome 12 trisomy in two separately grown samples of HiPSC 1-8 from Masaki et al. (2007). (D) The parental somatic cell and HiPSC 1-8 from different passages (14 and 31), showing trisomy in chromosome 12 (Bonferroni corrected p-values = 6.0 × 10−10 by Expander and 1.0∗10−18 by EASE, for passage 14; 5.0∗10−36 and 1.3∗10−26, for passage 31). (E) Moving average plot of the gene expression profile of clone 1-8 at passages 14 and 31, clone 3-2 is presented as normal reference. These results suggest a trisomy of chromosome 12, which was acquired very early in culture and gradually took over. Asterisks indicate p value < 1∗10−4, judged by Expander and EASE location analyses after Bonferroni multiple test correction. For further examples of detection of aneuploidy in HiPSCs, see also Figure S2. For a detailed list of HiPSC lines, see Table S2. Cell Stem Cell 2010 7, 521-531DOI: (10.1016/j.stem.2010.07.017) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 3 Generation of Trisomy 12 in HiPSCs upon their Growth in Culture (A) Karyotype analysis of hiPSC18 at passage 45. This cell line was also found normal by Array CGH-analysis at passage 48 (Chin et al., 2009). (B) hiPSC18 at passage 58 acquired a full trisomy of chromosome 12 in approximately half the population (9/20 metaphases). Normal and trisomic karyotypes from the same analysis are presented. (C) By passage 63 of hiPSC18 trisomy 12 cells had taken over the culture. (D) Whole chromosome gain analysis of hiPSC18 showing this cell line was normal at passage 9. (E) Full trisomy of chromosome 12 was detected at passage 63 (Bonferroni corrected p value = 4.3 × 10−47 by Expander and 1.6 × 10−38 by EASE). (F) Moving average plot of the gene expression profile of hiPSC18 at passages 9 and 63. Cell Stem Cell 2010 7, 521-531DOI: (10.1016/j.stem.2010.07.017) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 4 Functional Analysis of Recurring Chromosomal Aberrations in HiPSCs (A) Ideogram representing gained chromosomal regions identified by PCF analysis. Red bars represent a gain of the respective chromosomal region in one line. Dark and light bars represent gains in HiPSCs and HESCs, respectively. Similar chromosomal aberrations in different passages of the same cell line are interconnected by a line. (B) Representation of chromosome 12 gains identified by PCF analysis. Each bar represents a gain of the respective chromosomal region. (C) Comparison of NANOG and GDF3 expression between the five aberrant HiPSCs and HiPSCs lines with normal chromosome 12 copy number, showing that both genes are significantly overexpressed in the lines with gains in chromosome 12 (p values = 4.3 × 10−5 and 2.9 × 10−10; average fold changes ×1.6 and ×4.4, respectively; error bars represent SEM). (D) qRT-PCR expression of NANOG and GDF3 at three different passages of hiPSC18, demonstrating their expression increase upon selection for trisomy 12 in the culture (normalized to β-Actin). Asterisks indicate p value < 0.05. (E) Volcano plot showing overexpression and underexpression of genes residing in the minimal gained region common to all five aberrant HiPSCs, in these aberrant lines relative to lines with normal chromosome 12 copy number. (F) Schematic model of the different types of chromosomal aberrations found in HiPSCs: aberrations with somatic cell origin (“A”); aberrations present in early passage but without apparent somatic cell origin (“B”); and aberrations acquired during prolonged culture (“C”). Cell Stem Cell 2010 7, 521-531DOI: (10.1016/j.stem.2010.07.017) Copyright © 2010 Elsevier Inc. Terms and Conditions